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Abstract
Background: We have developed a high-throughput amplification method for generating robust gene expression profiles
using single cell or low RNA inputs.
Methodology/Principal Findings: The method uses tagged priming and template-switching, resulting in the incorporation
of universal PCR priming sites at both ends of the synthesized cDNA for global PCR amplification. Coupled with a whole-
genome gene expression microarray platform, we routinely obtain expression correlation values of R
2,0.76–0.80 between
individual cells and R
2,0.69 between 50 pg total RNA replicates. Expression profiles generated from single cells or 50 pg
total RNA correlate well with that generated with higher input (1 ng total RNA) (R
2,0.80). Also, the assay is sufficiently
sensitive to detect, in a single cell, approximately 63% of the number of genes detected with 1 ng input, with approximately
97% of the genes detected in the single-cell input also detected in the higher input.
Conclusions/Significance: In summary, our method facilitates whole-genome gene expression profiling in contexts where
starting material is extremely limiting, particularly in areas such as the study of progenitor cells in early development and
tumor stem cell biology.
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Introduction
Recently, there has been growing interest in obtaining gene
expression profiles from single cells, as it has become increasingly
evident that the heterogeneity present in cell populations is such
that population-based transcriptional profiles may not reflect the
regulatory networks functional at the individual cell level [1,2].
Applications for single cell gene expression profiling include
lineage determination in early development and organogenesis,
including embryogenesis [3,4], neuronal [5–8] and glial [9] cell
differentiation, hematopoietic [10,11], bone marrow stromal [12],
epidermal [13], heart [14,15] and pancreatic [16] stem cell
biology. Apart from facilitating cell lineage mapping an additional
key utility of single cell transcriptomics is in clinical diagnostics,
particularly the identification of gene expression signatures in
circulating tumor cells for use as prognostic markers for metastatic
tumors [17] and treatment response [18].
The analysis of single cancer cells can potentially overcome the
shortcomings of tumor heterogeneity and help pinpoint driver
mutations that spur the initial development of tumors, and identify
which mutations lead to metastasis, cancer progression and
resistance to therapy. However, a key technological challenge in
the transcriptional profiling of single cells is that most whole-
genome amplification protocols suffer from significant amplifica-
tion bias. While there have been several recent advancements in
the capture and isolation of single cells, such as cell picking [19,20]
and microfluidic [1,17,21] devices, there remains a need for the
development of high-throughput, whole-genome gene expression
assays for single cells. Example of previously reported assays aimed
at attempting to overcome the limitation of single cell or near
single cell quantities of starting material [for reviews see [4,22,23]]
include terminal continuation [24], homomeric tailing [3,10],
Ribo-SPIA technology (Ovation Pico WTA and WT-Ovation
One-Direct Amplification Systems) [25,26], TransPlex Whole
Transcriptome Amplification technology (Pico Profiling) [27],
template switching [28,29], multiple displacement amplification
(total transcript amplification [30]) and linear antisense RNA
amplification [6,8].
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employed in most of these studies include either linear antisense
RNA amplification or homomeric/TdT tailing followed by
exponential amplification. While the former approach has been
a mainstay for amplifying nanogram amounts of total RNA, there
have been relatively few studies in which single cell quantities have
been assayed [6,8]. Reported disadvantages to this approach
include inefficiencies during second strand cDNA synthesis and
purification [31], a multi-day workflow [32], time-dependent RNA
degradation [33], as well as transcript representation bias [34] all
of which are associated with successive rounds of amplification.
Variations of the latter approach include A- [3,4] or G-tailing [10]
in order to tag the 39 end of the first cDNA strand for global PCR
amplification. A third strategy by which cDNA may be tagged
makes use of a reverse transcriptase with terminal transferase
activity facilitating template-switching [20,28,35,36]. Other op-
tions by which the 39 termini of cDNAs may be tagged, include
linker/adaptor ligation [37] or the use of a terminal-tagging oligo
(TTO) [38]. The linker/adaptor ligation protocol generally
requires several additional enzymatic and washing steps, and is
therefore not only prone to loss of material, but also cross-
contamination. Because both of these methods currently require
nanogram quantities of total RNA as inputs, it is likely that the
efficiency with which mRNAs are converted into tagged and
amplifiable cDNA templates is lower than either the template-
switch or homomeric/TdT tailing methods. Recently, a Q29 DNA
polymerase-based multiple displacement amplification method
was described in which the transcriptomes of single bacterial cells
were profiled, yielding assay reproducibilities of R
2,0.80 [30].
While, currently this isothermal technology is adapted for
prokaryotes, the authors suggest that it may be modified for use
within a eukaryotic context.
Many of these approaches have not been widely adopted either
because they suffer from amplification bias, are not sufficiently
scalable or robust for high-throughput applications, are not
suitable in eukaryotic contexts, or a combination of these factors.
Here we describe a template-switch-based high-throughput
method that is capable of generating robust whole-genome gene
expression profiles at the single cell level.
Results
The pre-amplification method described here exploits the
template switching ability of some reverse transcriptases which
allows the 39 tagging of cDNA, thereby facilitating the incorpo-
ration of universal PCR primer sites at both ends of the
synthesized cDNAs (Fig. 1). Here we report on the comprehensive
characterization of the performance of our single cell gene
expression assay, termed Whole-Genome Gene Expression in
Single Cells (WG-XSC), using picogram quantities of total RNAs,
as well as a variety of different single cell types. We describe the
utility of the WG-XSC assay in the transcriptional profiling of
single cells and low input material, for which existing conventional
methods are not sufficiently sensitive.
Pre-Amplification Assay Optimization
Previous template-switching-based amplification protocols uti-
lized oligo-dT-based priming for cDNA synthesis followed by a
single-phase PCR amplification reaction [20,28,35,36]. We made
several modifications to these specific steps that led to substantial
improvements in both the cDNA yield and representation of single
cell quantities of starting material. These improvements are
summarized in Table 1.
We first assessed the impact of different cDNA priming methods,
during the reverse transcriptase step, on the performance of our
assay. Here we evaluated three conditions, namely: oligo-dT (T30),
oligo-dT + random hexamer (T30+N6) or oligo-dT + random
nonamer (T30+N9). Replicate inputs of 50 pg H9 cell total RNA
wereused foralltestedpriming conditions afterwhichpre-amplified
products were used as inputs for the 24 K WG-DASL Assay. While
typical assay reproducibilities of R
2,0.37 were obtained for the
T30 condition, improved self-correlations of R
2,0.63 were
observed for both the T30+N6 and the T30+N9 priming conditions
(Table 1). We also obtained a concomitant 58% increase in the
Figure 1. Pre-amplification scheme. (1) First strand cDNA synthesis is primed with tagged oligo-dT and random 9-mer primers. The tagged oligo-
dT primer contains a VN anchor followed by a T-30 stretch with a 59 PCR tag. The tagged random 9-mer consists of a 9-mer followed by the identical
59 PCR tag. (2) Upon reaching the 59 terminus of the mRNAs, the reverse transcriptase, via its terminal transferase activity, adds a few nucleotides
(predominantly deoxycytidine) to the 39 end of the newly synthesized cDNAs. (3) The template-switch primer, which consists of the same 59 PCR tag
as well as a 39 riboguanine stretch, anneals via GC complimentary base-pairing to the 39 end of the cDNAs, thereby serving as a new template for the
reverse transcriptase. (4) After cDNA synthesis, both ends of the cDNAs now contain the identical PCR tag, allowing exponential amplification of the
entire cDNA population through single primer PCR (5).
doi:10.1371/journal.pone.0030794.g001
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yielding approximately 10449 and 10332 probes detected (p,0.01)
for the T30+N6 and T30+N9 conditions, respectively, compared
with6595 detected probes (p,0.01) forthe T30condition(Table1).
Moreover, raw intensity correlations of the lower 50 pg with the
higher 1 ng input yielded R
2,0.69 for both the T30+N6 and the
T30+N9 priming conditions, while yielding R
2,0.47 for the T30
condition (Table 1). Our results clearly demonstrate an improve-
ment in the assay performance with the oligo-dT + randomer
compared to the oligo-dT priming.
Previous experiments performed with different numbers of PCR
cycles (15, 18, 21, 24 and 27 cycles) using different RNA inputs
(50 pg and 1 ng) demonstrated that the assay performance
(reproducibility, sensitivity and correlation with higher inputs), was
poorest at the extremes of our chosen cycle ranges (15 and 27), but
optimal at 21 PCR cycles (data not shown). To reduce the impact of
stochastic effects on low copy numbers during the early cycles, we
sought to improve the efficiency and fidelity of amplification by
applying an altered thermal profile for the first few PCR cycles. We
next therefore assessed the effect of two different PCR cycling
profilesonour assayperformance,namelya single-phaseprofile with
an annealing temperature of 65uC, and a 24 cycle, two-phase profile
consisting of an initial five PCR cycles carried out at a lower
annealing temperature (58uC), followed by 19 cycles at a higher
(65uC) annealing temperature (see Materials and Methods for
details). For this experiment, replicate inputs of 50 pg UHR total
RNA were processed using the 24 K WG-DASL Assay. Typical
results showed superior performance using the two-phase condition,
as assessed by measures of reproducibility (from R
2,0.37 for the
one-phaseand R
2,0.48 for thetwo-phaseconditions)andsensitivity
(,6595 probes detected for the one-phase and 8019 probes detected
for the two-phase conditions, p,0.01) (Table 1). This corresponded
to a 22% higher assay sensitivity for the two-phase profile.
Comparing raw correlations between lower 50 pg input RNA
amounts to higher 1 ng inputs, the one-phase and two-phase PCR
conditions yielded R
2,0.47 and R
2,0.59, respectively (Table 1).
Together these data demonstrate an improved performance of the
two-phase condition as compared with the one-phase profile.
Performance with RNA Inputs and Single Cells
A key performance characteristic of any single cell genomics
assay is its ability to discriminate among different samples at low
input levels. In order to further characterize our assay we used
T30+N9 priming together with the two-phase PCR profile
described earlier to assay two different RNA inputs. Triplicate
aliquots of UHR and BR, each at 10 pg, 50 pg and 1 ng total
RNA were used in conjunction with the 29 K WG-DASL HT
Assay. RNA quality was assessed using the Bioanalyzer 2100 and
yielded RIN values of 9.6 and 9.2 for the UHR and BR samples,
respectively (data not shown). On average, our intra-sample self-
reproducibilities were R
2,0.42, R
2,0.69 and R
2,0.96 for the
10 pg, 50 pg and 1 ng UHR and R
2,0.34, R
2,0.61 and
R
2,0.95 for the 10 pg, 50 pg and 1 ng BR RNA inputs,
respectively (Fig. 2A, Table 1). By contrast, comparisons between
the UHR and BR RNA samples, at the 50 pg input level, yielded
inter-sample correlations of R
2,0.39 (Fig. 2A), whereas UHR vs.
BR inter-sample correlations at the 1 ng input level yielded
R
2,0.61, suggesting that, based on gene expression profiles, our
assay can reliably differentiate between different low RNA inputs.
Having obtained robust data using picogram quantities of RNA,
we next repeated the experiment, using individual cells as inputs.
Here we used single HeLa and primary brain tumor (BT) cells. As
before, all samples were processed in triplicate. We observed a
similar trend to that obtained for the RNA equivalent inputs, with
intra-sample self-reproducibilities of R
2,0.76 (Fig. 2B, Table 1)
and R
2,0.74 for the HeLa and BT samples, respectively, while
the inter-sample correlations between the HeLa and BT single cell
samples were lower with R
2,0.57 (Fig. 2B). The differences
between the intra- and inter-sample average correlations were
statistically significant as reported by Student’s t-test (intra-sample
HeLa R
2 vs. inter-sample HeLa-BT R
2, p=1.34E-7; intra-sample
BT R
2 vs. inter-sample HeLa-BT R
2, p=2.80E-6). Apart from
different single cells, we also profiled 5-cell (HeLa) inputs, and
obtained self-correlations of R
2,0.88. We also compared the
single cell HeLa and BT expression profiles with that obtained for
50-cell inputs for tumorspheres (TS) and their adherent cell (AC)
counterparts. While the intra-sample correlations for the TS and
AC samples yielded R
2 of 0.89–0.95 (Fig. 2B), the inter-sample
correlations between the TS/AC vs. HeLa and the TS/AC vs. BT
cells yielded R
2 of ,0.45 and ,0.40, respectively. Together these
results indicate that our whole-genome gene expression assay can
robustly discriminate among different individual cell types.
We next ranked the fold-change differences between the TS and
the AC samples and further analyzed the top 100 over-expressed
Table 1. Values are averages for at least two technical replicates.
Table 1. Optimization of Preamplification Assay
Input Condition Self-Reproducibility (R
2)
Correlation
with 1 ng (R
2) Sensitivity
a
Probe
Concordance (%)
b
50 pg UHR total RNA
c T30 + one-phase PCR 0.374 0.473 6595 95.9
50 pg UHR total RNA
c T30 + two-phase PCR 0.481 0.585 8019 95.1
50 pg H9 total RNA
c T30 + N6 + one-phase PCR 0.626 0.695 10449 92.4
50 pg H9 total RNA
c T30 + N9 + one-phase PCR 0.627 0.688 10332 92.2
50 pg UHR total RNA
d T30 + N9 + two-phase PCR 0.698 0.806 13443 96.6
Single HeLa cells
d T30 + N9 + two-phase PCR 0.757 0.801 11083 97.4
Values shown for the self-reproducibility and correlation are derived from all probes.
aSensitivity is calculated as the number of probes detected at p-value,0.01.
bProbe concordance is calculated as a percentage of the number of probes with matching detected calls at p-value,0.01 between the low (50 pg or single cell) and
standard (1 ng) inputs divided by the total number of probes detected in the lower input.
c24 K WG-DASL.
d29 K WG-DASL HT.
doi:10.1371/journal.pone.0030794.t001
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PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e30794Figure 2. Raw signal intensity correlations between replicates of low input RNAs and whole cells. (A) 50 pg UHR and BR total RNA and
(B) single HeLa and brain tumor (BT) cells; 50 cell tumorsphere (TS) and adherent cells (AC). Pair-wise scatterplots of at least two replicates for each
input type are shown for all 29 K probes across the full range of raw signal intensities. Correlations are the square of Pearson’s correlation coefficient.
doi:10.1371/journal.pone.0030794.g002
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their attached counterpart. Using DAVID [39] we extracted GO
terms and compared the relative frequencies of these terms in each
list to that in the human genome to identify statistically significant
enriched GO terms. Within the over-expressed gene list several
transcription factors such as SMAD2, SHOC2 and KLHL7 were
included under the enriched GO term ‘‘nucleus’’ (p=8.71E-3)
consistent with a stem cell (Fig. S1) versus a more differentiated
cellular phenotype. Conversely, for the under-expressed genes
over-represented GO terms included ‘‘cell/biological adhesion’’
(p=3.83E-5) as well as ‘‘extracellular space’’ (p=5.34E-3)
suggestive of a cell-matrix adhesion pathway for an attached
(Fig. S1) as opposed to a suspended cell culture.
In order to determine the extent to which the gene expression
profiles obtained at low input levels correlated with those obtained
with higher inputs, we directly compared raw signal intensities
between the lower and higher inputs. Correlations between 50 pg
and 1 ng total RNA typically yielded R
2,0.80 (Fig. 3A, Table 1),
whereas correlations between 10 pg and 1 ng total RNA typically
yielded R
2,0.59 (Fig. 3B). Single cell correlations with 1 ng total
RNA, derived from a corresponding bulk cell culture, yielded
R
2,0.80 (Fig. 3C, Table 1). At p,0.01, we detected ,13443 and
10180 probes for the 50 and 10 pg RNA inputs, respectively,
whilst detecting ,14156 and 11083 probes for the 5-cell and
single cell inputs (Table 1), respectively. This level of sensitivity
represents approximately 77% (50 pg), 58% (10 pg), 80% (5-cell)
and 63% (single cell) of the total number of probes detected in the
higher, standard inputs. Furthermore, when the lists of probes
detected (p,0.01) in the lower inputs were intersected with those
detected in the higher 1 ng inputs, we obtained probe concor-
dance values of ,96.6%, 97.1% and 97.4% for the 50 pg (Fig. 3D,
Table 1), 10 pg (Fig. 3E) and single HeLa cells (Fig. 3F, Table 1),
respectively. The percentage of false positive probes detected in
the lower inputs was ,2% of the total number of probes detected
in the higher standard inputs. Taken together these results
demonstrate that our assay is sufficiently sensitive to reliably
detect, in low inputs, most of the genes that are detected at
standard higher inputs, and that the expression profiles derived
from these lower inputs accurately recapitulate those obtained in
higher inputs.
Discussion
Over the last few years there have been several reported studies
on either single cell gene expressing profiling using low gene
density (1–100) assays [1,2,16,40–42], or inputs of small
populations of cells (10–150) [27,43] or 100 pg–1 ng total RNA
[44–46] at the whole transcriptome level. Very few genome-wide
studies have been reported in which the assay performance has
been rigorously characterized using whole single cells or RNA
equivalents as inputs [3,4,10,47].
Our WG-XSC assay is highly reproducible, typically yielding
R
2,0.76 and ,0.69 for single cell and 50 pg RNA inputs,
respectively. The transcript representation as assessed by the
correlation between lower inputs and larger standard inputs
yielded R
2,0.80 and ,0.81 for single cell and 50 pg RNA inputs,
respectively. Of the few microarray-based single cell transcrip-
tional studies with self-correlation metrics the reported R values
range between 0.73–0.91 [3,10,48]. Exact comparisons between
these studies and the current study is challenging as either the
underlying experimental designs differ [10] or the analysis
methods are different [3,10,48]. A recent mRNA-Seq study in
which single mouse oocytes were assayed, reported assay
reproducibilities of R
2,0.97 [4]. It should be noted however that
these cells are atypical in size and therefore are also not directly
comparable with the current study.
Two obvious, but critical steps that could impact levels of
reproducibility and representation include the extent of cell lysis
as well as the efficiency with which low abundance mRNA
molecules are converted to cDNA. In order to minimize the loss
of material, and maximize the synthesis of cDNA in an unbiased
fashion, our protocol specifically incorporates the use of a
Figure 3. Intensity and detected probe concordance comparisons between low and higher 1 ng inputs. Raw signal intensity correlations
between (A) 50 pg (x-axis) and 1 ng (y-axis) UHR total RNA; (B) 10 pg (x-axis) and 1 ng (y-axis) UHR total RNA; (C) single HeLa cell (x-axis) and 1 ng (y-
axis) HeLa total RNA. The overlapping sets of detected probes between the low and higher inputs are shown for both the RNA equivalent (D, E) and
single cell (F) inputs. All probe values shown are at a threshold of p,0.01.
doi:10.1371/journal.pone.0030794.g003
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ware for single cell isolation, oligo-dT and random priming
for cDNA synthesis and a two-phase thermal profile for PCR
amplification.
An additional feature of our approach is the ability to process up
to 96 samples in parallel, thereby greatly reducing the associated
labor costs as well as minimizing variation/bias that may arise
from handling individual samples. This feature is of particular
relevance for single cell expression profiling where substantial
variation in transcript levels among phenotypically identical single
cells has been well documented, thereby necessitating the
simultaneous analyses of large numbers of individual cells [2,20].
In summary, our method facilitates whole-genome gene expression
profiling in contexts where starting material is extremely limiting,
particularly in areas such as the study of progenitor cells in early
development and tumor stem cell biology.
Our high-throughput assay generates whole-genome gene
expression profiles with single cell or low RNA inputs. This robust
and scalable method for profiling a variety of cell types at the
single cell level can be applied to critical questions in a broad
range of areas, including developmental biology and cancer
biology. We have used the technology for gene expression profiling
in circulating tumor cells isolated from prostate cancer and
ovarian cancer patients’ blood, as well as molecular and functional
characterization of early lineage commitment of human hemato-
poietic stem cells (data not shown). The ability to obtain genome-
wide gene expression data on many individual cells in parallel will
be extremely valuable in a variety of contexts, including detailed
molecular lineage tracing studies and clinical studies aimed at
biomarker discovery.
Materials and Methods
RNA Extraction
RNA from the WA09 (H9) [49] human embryonic stem cell line
was extracted using TRIzol (Life Technologies/Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s instructions
after which the precipitated RNA pellet was resuspended in 10 ml
RNase-free water. Commercial RNAs were purchased from the
following vendors, FirstChoice Human Cervical Adenocarcinoma
(HeLa-S3) and FirstChoice Human Brain Reference (BR) (both
from Life Technologies/Ambion, Austin, TX, USA) and Univer-
sal Human Reference (UHR) (Agilent/Stratagene, Santa Clara,
CA, USA). Different inputs, as indicated in the Results section,
were used for each pre-amplification reaction.
Sorting of Cultured Cells with a Phase-Switch
Microfluidics Device
A microfluidics device with a phase-switch feature was used for
isolating individual cells. Briefly, cultured cells were harvested with
trypsinization and washed with PBS, whereafter a single cell
suspension in PBS was load into a phase-switch microfluidics
device for encapsulation of individual cells into droplets. Cells were
encapsulated from the aqueous phase (PBS) into droplets in the oil
phase by either laser-cavitation or T-junction break-up of
immiscible threads as previously described [50]. With optimized
parameters, each droplet contained only one single HeLa.S-Fucci
(RIKEN BioResource Center Cell Bank, Ibaraki, Japan) [51] or
brain tumor (BT) cell. This was visually confirmed under a
fluorescent microscope. This approach minimizes the stress on
sorted cells and facilitates the manipulation of single cells in
droplets. Individual sorted cells were aliquoted in #1 ml Single cell
Lysis Buffer (SLB, Illumina, Inc.).
Culture of Tumorspheres and Adherent Cells
An ovarian cancer cell line, RMG1 [52] was cultured in three
T-150 flasks until 80–90% confluency in M199/MCDB105
medium (Sigma, St. Louis, MO, USA) supplemented with 5%
FBS (HyClone Laboratories Ltd., Logan, UT, USA), penicillin
(100 U/ml), and streptomycin (100 mg/ml). To culture under stem
cell conditions [53] cells were trypsinized and then resuspended in
DMEM/F12 medium supplemented with 5 mg/ml insulin (Novo
Nordisk Inc., Princeton, NJ, USA), 20 ng/ml epidermal growth
factor (R&D Systems, Inc., Minneapolis, MN, USA), 10 ng/ml
basic fibroblast growth factor (Invitrogen, Carlsbad, CA, USA),
0.4% bovine serum albumin (BD Falcon; Bedford, MA, USA),
penicillin (100 U/ml), and streptomycin (100 mg/ml) in two
100 mm Ultra Low Attachment plates (Corning, Lowell, MA,
USA) over three weeks. Spheroids were selected using a 40 mm cell
strainer (BD Falcon, Bedford, MA, USA), after which half of the
spheroids were cultured in one 35 mm dish (adherent cells, AC)
and the other half were grown in one well of one 6 well low
attachment plate in stem cell medium (tumorspheres, TS) for two
days. Cells were grown at 37uC in a 5% CO2/air atmosphere. The
brain tumor (BT) cells, derived from U118 human glioblastoma
cells (ATCC HTB-15), were purchased from the ATCC (Rock-
ville, MD, USA) and maintained in DMEM supplemented with
10% fetal bovine serum, glutamine, and penicillin/streptomycin as
recommended by the ATCC.
Cell Lysis, cDNA Synthesis and Pre-Amplification
All cell lysis and cDNA reactions were performed using 0.2 ml
Maxymum Recovery PCR tubes (Axygen, Union City, CA, USA).
The cell lysis, reverse transcription, template switching and pre-
amplification reactions were all performed in a single tube. Briefly,
for cell lysis, 1.8 ml SLB was added directly to the isolated single
cell. Tubes were placed in a thermocycler and heated to 72uC for
3 min, followed by five min at 4uC. After cell lysis, 3.2 ml Single
cell cDNA Synthesis Buffer (SCB, Illumina, Inc.) was added to the
lysed single cell. The reverse transcription and template switching
reactions were performed at 42uC for 60 min, followed by a
10 min 70uC inactivation step. After cDNA synthesis 32 mlo f
Single cell PCR Mix (SPM, Illumina, Inc.) was added directly to
the unpurified products followed by amplification using a PCR
cycling profile which consisted of an initial denaturation of 95uC
for 1 min, followed by 5 cycles of (95uC for 20 sec 58uC for 30 sec
and 68uC for 3 min), 9 cycles of (95uC for 20 sec, 65uC for 30 sec
and 68uC for 3 min), 10 cycles of (95uC for 30 sec, 65uC for 30 sec
and 68uC for 3 min+6 sec/cycle) and 1 cycle of 72uC for 10 min.
For cell-equivalent RNA inputs, the SLB and SCB were added
directly to the RNA (the cell lysis step was omitted) and were
reverse-transcribed and pre-amplified in the identical manner to
that described for the cell lysates.
Whole-Genome DASLH Assay
For whole-genome gene expression analysis, we used either the
Whole-Genome DASL Assay or the Whole-Genome DASL HT
Assay, an updated version of the original Whole-Genome DASL
Assay [54]. Briefly, the WG-DASL assay probes ,24 K targets
(,18 K unique genes) and uses the HumanRef-8 v3 BeadChip,
while the WG-DASL HT Assay interrogates ,29 K targets
(,21 K unique genes), based on content derived from the
National Center for Biotechnology Information Reference Se-
quence Database (Release 98, November 2009) and uses the
Human HT-12 v4 BeadChip. For both 24 K and 29 K assays we
used 10 ml of the 37 ml (27%) pre-amplified cDNA product which
we annealed directly to the 24 K or 29 K oligo pool and then
proceeded exactly as previously described [54].
Whole-Genome Gene Expression of Single Cells
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Unless otherwise stated, all data were analyzed in an un-
normalized, raw state. All individual samples were assayed a
minimum of two times. After scanning, intensity data were
imported into GenomeStudioH v2.0 where the data quality was
assessed using several assay controls. Detection p-values were
computed using several hundred negative controls to determine
gene expression detection limits. Assay performance metrics are
described further in the Results section. All of the microarray data
are MIAME-compliant (http://www.mged.org/Workgroups/
MIAME/miame.html) and have been submitted to GEO
(Accession Number: GSE34365). Over-representation analysis of
differentially expressed genes was performed using DAVID [39],
which reports functional gene categories as statistically significant
gene ontology (GO) terms.
Supporting Information
Figure S1 Ovarian cancer cells (RMG1) were cultured in
stem cell media. (A) a spheroid in an ultra-low attachment
plate, (B) a spheroid in a tissue-culture treated plate, after two days
in a regular plate. Scale bar=90 mm.
(PDF)
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